Yurii Morozov

Dr. Yurii Morozov


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 May 2024 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
TSTatyana Shabatina
Tatyana Shabatina
YGYana Andreevna Gromova
Yana Andreevna Gromova
OVO. I. Vernaya
O. I. Vernaya
ASAndrei V. Soloviev
Andrei V. Soloviev
ASAndrey Shabatin
Andrey Shabatin
MMMikhail Melnikov
Mikhail Melnikov
The use of medicinal substances in nanosized forms (nanoforms, nanoparticles) allows the therapeutic effectiveness of pharmaceutical preparations to be increased due to several factors: (1) the high specific surface area of nanomaterials, and (2) the high concentration of surface-active centers interacting with biological objects. In the case of drug nanoforms, even low concentrations of a bioactive substance can have a significant therapeutic effect on living organisms. These effects allow pharmacists to use lower doses of active components, consequently lowering the toxic side effects of pharmaceutical nanoform preparations. It is known that many drug substances that are currently in development are poorly soluble in water, so they have insufficient bioavailability. Converting them into nanoforms will increase their rate of dissolution, and the increased saturation solubility of drug nanocrystals also makes a significant contribution to their high therapeutic efficiency. Some physical and chemical methods can contribute to the formation of both pure drug nanoparticles and their ligand or of polymer-covered nanoforms, which are characterized by higher stability. This review describes the most commonly used methods for the preparation of nanoforms (nanoparticles) of different medicinal substances, paying close attention to modern supercritical and cryogenic technologies and the advantages and disadvantages of the described methods and techniques; moreover, the improvements in the physico-chemical and biomedical properties of the obtained medicinal nanoforms are also discussed.

17 June 2021 in Nanomaterials
Verified
Journal Article
Open access
PDF file
TSTatyana Shabatina
Tatyana Shabatina
YMYurii Morozov
Yurii Morozov
ASAndrey V. Soloviev
Andrey V. Soloviev
ASAndrey Shabatin
Andrey Shabatin
OVO. I. Vernaya
O. I. Vernaya
MMMikhail Melnikov
Mikhail Melnikov
Increasing the effectiveness of known, well-tested drugs is a promising low-cost alternative to the search for new drug molecular forms. Powerful approaches to solve this problem are (a) an active drug particle size reduction down to the nanoscale and (b) thermodynamically metastable but kinetically stable crystal modifications of drug acquisition. The combined cryochemical method has been used for size and structural modifications of the antibacterial drug 2,3-quinoxalinedimethanol-1,4-dioxide (dioxidine). The main stage of the proposed technique includes the formation of a molecular vapor of the drug substance, combined with a carrier gas (CO2) flow, followed by a fast condensation of the drug substance and CO2 molecules on a cooled-by-liquid nitrogen surface of preparative cryostate. It was established that the molecular chemical structure of the drug substance remained unchanged during cryochemical modification; however, it led to a significant decrease of the drug particles’ size down to nanosizes and changes in the crystal structures of the solid drug nanoforms obtained. Varying carrier gas (CO2) flow led to changes in their solid phase composition. A higher dissolution rate and changes in antibacterial activity were demonstrated for cryomodified dioxidine samples in comparison to the properties of the initial pharmacopeia dioxidine.

1 May 2014 in Russian Journal of General Chemistry
Verified
Journal Article
Closed access
PDF file
YMYurii Morozov
Yurii Morozov
AUA. Yu. Utekhina
A. Yu. Utekhina
VSV. P. Shabatin
V. P. Shabatin
VCVladimir Chernyshev
Vladimir Chernyshev
GSG. B. Sergeev
G. B. Sergeev
The specific features of cryochemical technology for producton of new nanosized modifications of drug substances are observed. The method is based on transformation of the initial substance in gas...

1 September 2016 in Moscow University Chemistry Bulletin
Verified
Journal Article
Closed access
PDF file
YMYurii Morozov
Yurii Morozov
VFV. V. Fedorov
V. V. Fedorov
VSV. P. Shabatin
V. P. Shabatin
OVO. I. Vernaya
O. I. Vernaya
VCV. V. Chernyshev
V. V. Chernyshev
GSG. B. Sergeev
G. B. Sergeev
Dynamic sublimation in a stream of heated carrier gas and low-temperature condensation are used to perform structural and dimensional modification of nonsteroidal anti-inflammatory preparation of...

21 August 2017 in Molecules
Verified
Journal Article
Open access
PDF file
YMYurii Morozov
Yurii Morozov
DCDmitry Chistyakov
Dmitry Chistyakov
VCVladimir Chernyshev
Vladimir Chernyshev
GSGleb Sergeev
Gleb Sergeev
A new cryochemical strategy of producing nanoparticles and polymorphous nanostructures of drugs is used, which is based on the dynamic combination of high and low temperatures, gas and solid phases, and inert carrier gases. This technology is applied to the synthesis of nanoparticles of steroid neurohormone dehydroepiandrosterone (DHEA). We have optimized the conditions of synthesis of the new polymorphous DHEA structure, FVII. The molecules of DHEA in FVII structure are bound by hydrogen bonds via oxygen atoms. The grain size is 100 nm. It is shown that the yield and ratio of the resulting nanoforms of this hormone are determined by the nature and properties of the inert carrier gas. The highest yield and selectivity of FVII are observed when carbon dioxide is used as the carrier gas. In the case of helium, the FVII content decreases from 85 to 30% and other structures are formed. In experiments without carrier gas, nanoparticles are formed but no FVII is produced. The selectivity and the effect of carrier gas are considered on the basis of homogeneous and heterogeneous formation of nanoparticles and the relationship between particle selectivity and its activity. The synthesis of various polymorphous structures on the nanoscale is assumed to be the manifestation of the size effect in the synthesis of drugs.

1 November 2024 in Differential Equations
Verified
Journal Article
Closed access
PDF file
IAI. V. Astashova
I. V. Astashova
YMYurii Morozov
Yurii Morozov
AFA. V. Filinovsky
A. V. Filinovsky
Gregory A. ChechkinGregory A. Chechkin
Gregory A. Chechkin
TSTatyana Shabatina
Tatyana Shabatina
For a nonlinear second-order ordinary differential equation arising when mathematically modeling cryochemical synthesis of medicinal nanoforms, the behavior of its positive monotone solutions is studied as well as the existence, uniqueness, and properties of solutions to various boundary value problems with fixed and free boundaries.